Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2003 1
2005 4
2006 2
2007 5
2008 7
2009 5
2010 3
2011 8
2012 2
2013 3
2014 2
2015 4
2016 5
2017 11
2018 9
2019 8
2020 9
2021 23
2022 13
2023 7
2024 7
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators. Wong F, et al. Among authors: mumtaz k. N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290. N Engl J Med. 2021. PMID: 33657294 Clinical Trial.
Update on endoscopic ultrasound-guided liver biopsy.
Rangwani S, Ardeshna DR, Mumtaz K, Kelly SG, Han SY, Krishna SG. Rangwani S, et al. Among authors: mumtaz k. World J Gastroenterol. 2022 Jul 28;28(28):3586-3594. doi: 10.3748/wjg.v28.i28.3586. World J Gastroenterol. 2022. PMID: 36161047 Free PMC article. Review.
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes.
Elsaid MI, Li N, Firkins SA, Rustgi VK, Paskett ED, Acharya C, Reddy KR, Chiang CW, Mumtaz K. Elsaid MI, et al. Among authors: mumtaz k. Aliment Pharmacol Ther. 2024 May;59(9):1096-1110. doi: 10.1111/apt.17925. Epub 2024 Mar 27. Aliment Pharmacol Ther. 2024. PMID: 38538967
Tropylium Ion, an Intriguing Moiety in Organic Chemistry.
Zahra FT, Saeed A, Mumtaz K, Albericio F. Zahra FT, et al. Among authors: mumtaz k. Molecules. 2023 May 15;28(10):4095. doi: 10.3390/molecules28104095. Molecules. 2023. PMID: 37241836 Free PMC article. Review.
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
Miah A, Tinoco G, Zhao S, Wei L, Johns A, Patel S, Li M, Grogan M, Lopez G, Husain M, Hoyd R, Mumtaz K, Meara A, Bertino EM, Kendra K, Spakowicz D, Otterson GA, Presley CJ, Owen DH. Miah A, et al. Among authors: mumtaz k. J Cancer Res Clin Oncol. 2023 May;149(5):2235-2242. doi: 10.1007/s00432-022-04340-3. Epub 2022 Sep 7. J Cancer Res Clin Oncol. 2023. PMID: 36070148 Free PMC article. Review.
126 results